Veracyte (VCYT) FY2021 results: revenue $220 million, up 86.8% on the year
Veracyte, Inc. (VCYT) reported revenue of $220 million for fiscal 2021, the year ended 31 December 2021, up 86.8% on the year before. Net income was -$76 million, and diluted earnings per share $-1.11. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2022.
Revenue
$220 million
+86.8% on the year
FY2014FY2021
Operating margin
-37.3%
-30.1% a year earlier
FY2014FY2021
Net income
-$76 million
FY2014FY2021
Diluted EPS
-$1.11
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
-31.6
-9.7
-3.2
Capital expenditure
5.4
2.8
2.8
+89.5%
Free cash flow
-37.0
-12.5
-6.0
Free cash flow margin
-16.9%
-10.7%
-5.0%
Cash from investing
-739
-3.8
-42.7
Cash from financing
596
204
127
+192.9%
Depreciation and amortisation
19.6
7.9
4.1
+146.6%
Share-based compensation
22.5
13.0
9.8
+73.3%
Diluted shares, weighted
68m
53m
46m
+27.5%
Shares outstanding at period end
71m
58m
50m
+22.2%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
1,097
421
239
+160.3%
Debt
1.1
0.8
0.7
+39.1%
Operating lease liabilities
14.1
9.9
11.5
+42.1%
Other liabilities
76.1
25.2
23.6
+201.9%
Total liabilities and equity
1,188
457
275
+159.8%
Fixed assets
15.1
9.0
8.9
+67.9%
Goodwill
708
2.7
2.7
+25,878.1%
Intangible assets
203
59.9
65.0
+238.3%
Securities held for sale or to maturity
4.0
n/a
n/a
Cash and equivalents
173
349
159
-50.4%
Receivables
41.5
18.5
19.3
+124.6%
Inventory
11.2
4.7
6.8
+141.0%
Other assets
32.2
13.0
13.1
+147.2%
Total assets
1,188
457
275
+159.8%
10-K for the year ended 31 December 2021, filed 28 February 2022: the filing.